These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 8870683)
1. Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene. Asano T; An T; Mayes J; Zwelling LA; Kleinerman ES Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):307-13. PubMed ID: 8870683 [TBL] [Abstract][Full Text] [Related]
2. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
3. Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide. Asano T; Zwelling LA; An T; McWatters A; Herzog CE; Mayes J; Loughlin SM; Kleinerman ES Br J Cancer; 1996 Jun; 73(11):1373-80. PubMed ID: 8645582 [TBL] [Abstract][Full Text] [Related]
4. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells. Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635 [TBL] [Abstract][Full Text] [Related]
5. Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha. Kuriyama M; Tsutsui K; Tsutsui K; Ono Y; Tamiya T; Matsumoto K; Furuta T; Ohmoto T Neurol Med Chir (Tokyo); 1997 Sep; 37(9):655-61; discussion 661-2. PubMed ID: 9330528 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells. Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516 [TBL] [Abstract][Full Text] [Related]
7. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells. Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205 [TBL] [Abstract][Full Text] [Related]
8. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta. Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262 [TBL] [Abstract][Full Text] [Related]
9. [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines]. Matsumoto Y; Takano H; Nagao S; Iglesias A; Fojo T Gan To Kagaku Ryoho; 1997 Dec; 24(15):2265-9. PubMed ID: 9422071 [TBL] [Abstract][Full Text] [Related]
10. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2. Harris LN; Yang L; Tang C; Yang D; Lupu R Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896 [TBL] [Abstract][Full Text] [Related]
11. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells. Asano T; Kleinerman ES; Zwelling LA; Zhou Z; Fukunaga Y Acta Oncol; 2005; 44(3):240-7. PubMed ID: 16076696 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor. Wang Q; Zambetti GP; Suttle DP Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219 [TBL] [Abstract][Full Text] [Related]
14. Decreased CP-1 (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIalpha in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226. Wang H; Jiang Zg; Wong YW; Dalton WS; Futscher BW; Chan VT Biochem Biophys Res Commun; 1997 Aug; 237(2):217-24. PubMed ID: 9268689 [TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of human topoisomerase IIalpha fragments and etoposide resistance in mammalian cells. Ernst AI; Soltermann A; Sigrist JA; Widmer L; Gasser SM; Stahel RA Int J Cancer; 2000 Oct; 88(1):99-107. PubMed ID: 10962446 [TBL] [Abstract][Full Text] [Related]
16. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Oloumi A; MacPhail SH; Johnston PJ; BanĂ¡th JP; Olive PL Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769 [TBL] [Abstract][Full Text] [Related]
17. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth. Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604 [TBL] [Abstract][Full Text] [Related]
18. [Correlation between DNA topoisomerase II alpha expression and sensitivity to etoposide in human glioma cell lines]. Hao YJ; Natsume A; Mizuno M; Taniguchi K; Wakabayashi T; Yoshida J Gan To Kagaku Ryoho; 2000 Aug; 27(9):1403-9. PubMed ID: 10969596 [TBL] [Abstract][Full Text] [Related]
19. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses. Morgan SE; Cadena RS; Raimondi SC; Beck WT Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ; White RL; Matsunami N; Neufeld KL Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]